Related Links and Publications

 

Publications

  1. Opgenorth D., Baig N., Fiest K. et al. LIBERATE: a study protocol for midodrine for the early liberation from vasopressor support in the intensive care unit (LIBERATE): protocol for a randomized controlled trial. Trials 23, 194 (2022). https://doi.org/10.1186/s13063-022-06115-0
  2. Kamaleldin M, Kilcommons S, Opgenorth D, et al. Midodrine therapy for vasopressor dependent shock in the intensive care unit: a protocol for a systematic review and meta-analysis. BMJ Open 2022;12:e064060. https://doi.org/10.1136/bmjopen-2022-064060.
  3. Kilcommons SJ, Hammal F, Kamaleldin M, Opgenorth DL, Fiest KM, Karvellas CJ, Kutsogiannis DJ, Lau VI, MacIntyre EJ, Rochwerg B, Senaratne JM, Slemko JM, Sligl WI, Wang XXM, Bagshaw SM, Rewa OG. Adjunctive Midodrine Therapy for Vasopressor-Dependent Shock in the ICU: A Systematic Review and Meta-Analysis. Crit Care Med. 2024 Dec 4;53(2):e384–99. doi: 10.1097/CCM.0000000000006519. Epub ahead of print. PMID: 39631091; PMCID: PMC11801447. https://journals.lww.com/ccmjournal/fulltext/9900/adjunctive_midodrine_therapy_for.426.aspx
  4. Kilcommons, S.J., Hammal, F., Opgenorth, D.L. et al. Midodrine for the early liberation from vasopressor support in the ICU (LIBERATE): a feasibility study. Pilot Feasibility Stud 10, 147 (2024). https://doi.org/10.1186/s40814-024-01577-2